Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 406-424
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Table 4 Chines University Prognostic Index
| Variable | Weight |
| TNM stage | |
| Iand II | -3 |
| IIIa and IIIb | -1 |
| IVa and IVb | 0 |
| Asymptomatic disease on presentation | -4 |
| Presence of ascites | 3 |
| AFP ≥ 500 ng/mL | 2 |
| Total bilirubin (μmol/L) | |
| < 34 | 0 |
| 34-51 | 3 |
| ≥ 52 | 4 |
| ALP ≥ 200 (IU/L) | 3 |
- Citation: Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.406